Dementia signs, symptoms may be different for Latinos, researchers say
By
Alicia Lasek
May 27, 2021
Cultural practices and disease processes may explain why Latino adults with dementia experience faster functional decline and higher rates of depression and anxiety, investigators say.
Investigators fast-track new UTI antibiotic for FDA approval
By
Alicia Lasek
Nov 07, 2022
A new oral antibiotic that targets the common causes of urinary tract infections has proven highly successful in clinical trials.
Common diabetes drug may serve as novel Afib treatment
By
Alicia Lasek
Oct 13, 2022
If approved, it would be the first new drug identified to treat this disease of the heart in a decade, according to Cleveland Clinic researchers.
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
Eli Lilly aims for dementia drug candidate’s approval in 2022; wants to ‘prioritize access’
By
Alicia Lasek
Aug 04, 2021
The Alzheimer’s disease-modifying drug donanemab is on track to be considered for full FDA approval by 2022, its developer said.
Clinicians should be on lookout for cognitive changes after CVD events: study
By
Alicia Lasek
Mar 06, 2023
People who experience adverse health events linked to cardiovascular disease may have a higher incidence of dementia, a new study finds. The results highlight the need to monitor these patients for changes...
Most older adults would rather keep healthcare and religion separate, poll finds
Dec 15, 2022
Clinicians should keep their religious beliefs separate from how they deliver care, according to 77% of older adults queried in the University of Michigan’s National Poll on Healthy Aging.
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study
By
Alicia Lasek
Oct 19, 2021
Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...
CDC: Lasting COVID-19 symptoms tied to age, sex, race factors
By
Alicia Lasek
Sep 21, 2021
Investigators examined recovered COVID-19 patients in Long Beach California. Fully one third of participants reported having at least one symptom of post-acute sequelae, commonly called “long COVID-19,”...